TC-2216

From Wikipedia, the free encyclopedia
Jump to: navigation, search
TC-2216
TC-2216 structure.png
Systematic (IUPAC) name
8-pyridin-3-yl-1,8-diazaspiro[4.4]nonane
Clinical data
Legal status ?
Identifiers
ATC code ?
PubChem CID 10176607
Chemical data
Formula C12H17N3 
Mol. mass 203.283
 YesY (what is this?)  (verify)

TC-2216 is a drug developed by Targacept which acts as a partial agonist at neural nicotinic acetylcholine receptors and is being researched for the treatment of anxiety and depression.[1]

References[edit]

  1. ^ Romanelli, M.; Gratteri, P.; Guandalini, L.; Martini, E.; Bonaccini, C.; Gualtieri, F. (2007). "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–767. doi:10.1002/cmdc.200600207. PMID 17295372.  edit